Related Experiment Video
Updated: Jul 3, 2026

Isolation, Characterization, And High Throughput Extracellular Flux Analysis of Mouse Primary Renal Tubular Epithelial Cells
Published on: June 20, 2018
Analysis of renal impairment in children with Wilson's disease
Xiao-Hui Zhuang1, Ying Mo, Xiao-Yun Jiang
1Department of Pediatrics, First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
Insights
Wilson's disease (hepatolenticular degeneration) often presents with varied renal impairment in children. Early kidney evaluation is crucial for diagnosis and monitoring, especially during D-penicillamine treatment.
Area of Science:
- Pediatric Nephrology
- Hepatology
- Genetic Metabolic Disorders
Background:
- Wilson's disease (hepatolenticular degeneration, HLD) can manifest with diverse renal complications, leading to potential misdiagnosis.
- This study investigates the clinical characteristics of renal impairment in pediatric HLD patients.
Observation:
- Of 85 pediatric HLD patients, 34 exhibited renal impairment.
- Analysis of 25 patients revealed varied symptoms including edema, gross hematuria, acute renal failure, proteinuria, and hematuria.
- Biochemical and urinalysis findings indicated tubular damage and glomerular involvement, with one case showing IgA nephropathy.
Findings:
- Renal impairment in pediatric HLD is multifactorial, presenting with proteinuria, hematuria, and abnormal urine biomarkers.
- Some patients showed signs of acute kidney injury and glomerular changes, highlighting the spectrum of renal involvement.
- Corneal Kayser-Fleischer rings and decreased ceruloplasmin levels were consistent findings in affected children.
Implications:
- HLD should be considered in the differential diagnosis of unexplained renal impairment in children.
- Regular renal function and urinalysis monitoring are recommended for all HLD patients, particularly those undergoing D-penicillamine therapy.
- Early detection and management of renal complications can improve outcomes for pediatric patients with Wilson's disease.
Background:
Since the diverse manifestations of renal impairment appear in different periods of Wilson's disease, misdiagnosis or missed diagnosis is not rare. This study was undertaken to find the clinical features of renal impairment in children with Wilson's disease or hepatolenticular degeneration (HLD).
Methods:
Eighty-five children with HLD who had been treated at our department between January 1991 and June 2006 were retrospectively studied. The clinical data of 25 patients with renal impairment were analyzed.
Results:
In the 85 HLD patients, 34 had renal impairment. Nine of the 34 patients with D-penicillamine treatment were excluded. In the remaining 25 patients, 7 had initiated symptoms of renal impairment, 5 of them with edema, 1 with gross hematuria, and 1 with acute hemolysis and acute renal failure. Twelve of the 25 patients had proteinuria, 14 had hematuria, and 5 had both proteinuria and hematuria. Urine glucose was positive in 4 patients, urine N-acetyl-beta-D-glucosaminidase (NAG) increased in 5, and urine beta2-microglobulin increased in 6. Urine red blood cell (RBC) phase was detected in 7 patients, including glomerular hematuria in 5 patients and non-glomerular hematuria in 2. Blood urea nitrogen and creatinine increased in 1 patient. B-ultrasound revealed bilaterally enlarged kidneys in 3 patients. Kidney biopsy showed diffuse mesangial proliferation and IgA deposit in mesangial region in 1 patient. All of the 25 patients had cornea K-F ring and the level of ceruloplasmin decreased. Six patients had a family history of HLD.
Conclusions:
The manifestations of renal impairment with HLD are varied. HLD should be excluded from patients with unexplained renal impairment, while those with HLD should take examinations of the kidney to identify renal impairment. We propose that renal function and urinalysis should be checked regularly in patients receiving treatment of D-penicillamine.
Related Concept Videos
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Pharmacokinetics in Pediatric Patients: Drug Excretion
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
